3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-me...

Details 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-me... 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-me...

2006-10-10

2006-10-10

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S373000

Reexamination Certificate

active

07119093

ABSTRACT:
The present invention relates to the compound 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycabonyl-2-indolinone-monoethanesulphonate of formula I and the use thereof as a pharmaceutical composition

REFERENCES:
patent: 6762180 (2004-07-01), Roth et al.
patent: 2003/0092756 (2003-05-01), Roth et al.
patent: WO 01/27080 (2001-04-01), None
patent: WO 01/27081 (2001-04-01), None
patent: WO 02/081445 (2002-10-01), None
Traxler, Oncologic, vol. 7,p. 215-234 (2003).
Burke, Stem Cells, vol. 12, p. 1-6 (1994).

Affiliated with

Also associated with

Rating

3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-me... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-me..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-me... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3642978